Drugs & Targets

Drugs & Targets

St. John’s Cancer Institute, Absci partner to expedite cancer therapy development

Absci Corporation and St. John’s Cancer Institute entered into a partnership to uncover breakthrough cancer therapies. The partnership will leverage Absci’s Integrated Drug Creation platform, which combines generative AI models and proprietary wet-lab technologies, and SJCI’s cancer biospecimen repository and molecular database to quickly identify new therapeutic candidates with the potential for higher probability of clinical success.